GRI·3622AW106·US·equity·Healthcare - Biotechnology-13D/G
GRI (GRI BIO INC) is held by 4 institutional investors as of Q4 2025. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($5,721), VANGUARD GROUP INC ($4,199), BlackRock, Inc. ($52). Net institutional sentiment: Mixed.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer